News — ELISA Kits

We have entered a new era in the world of obesity treatment, with a clear and distinct focus being on glucagon-like peptide-1 (GLP-1) drugs. These innovative therapies, which mimic the GLP-1 hormone found in the gut, have been making waves in the medical community and beyond. In fact, they were named as the 2023 Breakthrough of the Year by Science.org. From Diabetes to Obesity: The Journey of GLP-1 Drugs The story of GLP-1 drugs began in the early 1980s during research into diabetes and blood sugar regulation. Scientists discovered that GLP-1 could lower blood sugar levels in people, leading pharmaceutical...